Trials Sponsors Conditions Drugs Pricing

Conditions

Acute Ischemic Stroke

Keywords

Large Vessel Occlusion Biomarkers TestThrombectomy

Outcome Measures

Primary Outcomes (1)

Specificity and sensibility of blood biomarkers in combination with neurological scales (NIHSS) determined before the thrombectomy intervention to predict the prognosis of the patient (functional dependence and mortality).
through the study completion, an average of one year

Secondary Outcomes (1)

Percentage of patients who suffer a futile recanalization after a mechanical thrombectomy.
3 months

Interventions

Large Vessel Occlusion Biomarkers TestDevice

Duplex Point of Care test to measure the concentration of blood biomarkers (FABP+NT-proBNP) associated to Large Vessel Occlusion in blood samples used in combination with an APP.

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodProbability Sample

Study Population

Stroke patients with large vessel occlusion treated by mechanical thrombectomy

You may qualify if:

Patients \> 18 years old.

Sponsors & Collaborators

Hospital Universitario Reina Sofia de Cordoba
Governmentcollaborator
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Otherlead

Study Sites (2)

Hospital Universitario Reina Sofía

Córdoba, Spain

RECRUITING

Fernando Delgado AcostaCONTACT

Hospital Universitario Virgen Rocío

Seville, Spain

RECRUITING

Alejandro González GarcíaCONTACT

MeSH Terms

Conditions

Ischemic Stroke

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Rosa M Delgado

CONTACT

955923067 trainingbioship@gmail.com

Carmen De Jesús Gil

CONTACT

955923067

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

June 14, 2024

First Posted

June 21, 2024

Study Start

April 9, 2024

Actual (reported)

Primary Completion

April 2025

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Blood Biomarkers to Predict the Prognosis of a Stroke Patient Undergoing Mechanical Thrombectomy

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (2)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (2)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations